Alcon Announces Launch of AcrySof IQ Vivity in India

Alcon Announces Launch of AcrySof IQ Vivity in India, the First and Only Presbyopia-Correcting Lens Implant with Proprietary Wavefront-Shaping Technology for Cataract Surgery

New Delhi (India), January 7: Alcon, the global leader in eye care dedicated to helping people see brilliantly, today announced the commercial launch of the first and only presbyopia-correcting intraocular lens (PC-IOL) with wavefront-shaping technology – the AcrySof® IQ Vivity® IOL (Vivity®). This new PC-IOL is now available to Indian ophthalmologists for their patients undergoing cataract surgery. Cataracts usually impact older adults and are often linked to presbyopia, which reduces the ability to view near objects and is the most common refractive disorder in patients undergoing cataract surgery.

Vivity is the first and only extended depth of focus lens with Alcon’s proprietary X-WAVE™ technology, which stretches and shifts light without splitting it. Vivity delivers a continuous range of vision at various distances like monofocal-quality distance (far) with excellent intermediate (at arm’s length, e.g., reading the newspaper, working on a laptop) and functional near (up close, e.g., reading books, mobile phone), with a clinically proven exceptionally low rate of visual disturbances. Commemorating World Sight Day on October 14, Vivity aims to meet the needs of cataract patients interested in enhanced visual performance, reduced spectacle dependence while enabling more independence.

Vivity expands Alcon’s growing portfolio of PC-IOLs and is built on Alcon’s trusted and proven AcrySof IQ IOL platform with implants exceeding 125 million eyes globally. According to results from two large independent clinical trials, patients who had the Vivity lens implanted experienced renewed vision and lifestyle benefits. Vivity patients reported 20/20 vision at a distance, more than 20/25 at intermediate and 20/32 for near vision. Additionally, 94% and 92% of Vivity patients reported superior vision at distance and arm’s length, respectively, without glasses in bright light.

Cataracts are the most common cause of vision loss globally and the primary cause of preventable blindness in India. Cataract surgery involves removing the clouded natural crystalline lens followed by a replacement with an intraocular lens (IOL). The prevalence of cataracts in India is 9.9 million; each year, 6.5 million surgeries are performed by around 12,200 cataract surgeons.

Among the 6.5 million undergoing cataract surgery in India, 90% of patients continue to depend on glasses for most of their daily activities even after surgery. An independent survey revealed that 95% of these patients expressed the willingness to get rid of glasses after the surgery. Sadly, despite the desire, there are several barriers. One of the significant barriers is the limitation of the current technology to address the visual needs of all patient groups.

“Traditional IOLs typically address distance vision. The new generation of seniors spend significant time with technology screens like phones, tablets and computers, and currently experience a massive gap in near and intermediate vision post-surgery,” said Shalav Modi, Country Franchise Head, Surgical, and Country Manager at Alcon Laboratories India Pvt Ltd. “Vivity addresses this gap and the desire of patients who want to get rid of cataracts and presbyopia at the same time. As a result, patients can be less dependent on glasses for most activities post-surgery, enhancing their visual satisfaction and quality of life,” Modi added.

Vivity is the first and only non-diffractive* presbyopia-correcting IOL with minimum visual disturbance profile. Unlike conventional presbyopia-correcting IOLs, which split light, Vivity utilizes almost all light energy, providing good vision quality in all lighting conditions. Vivity is approved by the Central Drug Standard Control Organization (CDSCO).

Leading ophthalmic surgeons worldwide who have had a chance to implant Vivity have said that they can now offer presbyopia correction to a more significant number of patients undergoing cataract surgery, with strong satisfaction rates. Based on a recent survey, 93% of patients said they would definitely recommend the new AcrySof Vivity to their friends and relatives.

16 COMMENTS

    Receive and send emails through your temporary messaging system. Use our webmail or your favorite email software with our absolutely free disposable email. temp mail

    Hmm it looks like your blog ate my first comment (it was extremely long) so I guess I’ll just sum it up what I
    had written and say, I’m thoroughly enjoying your blog. I as well am an aspiring blog writer but
    I’m still new to everything. Do you have any recommendations for rookie blog writers?
    I’d certainly appreciate it.

    Hey are using WordPress for your blog platform?
    I’m new to the blog world but I’m trying to get started and set up
    my own. Do you need any coding expertise to make your own blog?

    Any help would be greatly appreciated!

    Very nice post. I just stumbled upon your weblog and wanted to say
    that I’ve truly enjoyed browsing your blog posts.
    After all I will be subscribing to your rss feed and I hope you write again very soon!

    Hi there! I know this is kind of off topic but I was wondering which blog platform are you using
    for this site? I’m getting tired of WordPress because I’ve
    had problems with hackers and I’m looking at options for another
    platform. I would be great if you could point me in the
    direction of a good platform.

    The other day, while I was at work, my cousin stole my iPad and tested to see
    if it can survive a thirty foot drop, just so she can be
    a youtube sensation. My iPad is now destroyed and she has 83
    views. I know this is totally off topic but I had to share it with someone!

    I am extremely impressed with your writing skills as well as with the layout
    on your weblog. Is this a paid theme or did you customize it
    yourself? Anyway keep up the nice quality
    writing, it’s rare to see a nice blog like this one nowadays.

    You really make it appear so easy along with your presentation however I to find this
    topic to be really one thing which I think I would by no means understand.
    It kind of feels too complicated and very broad
    for me. I am looking forward for your next submit, I’ll try to get the hold of it!

    I enjoy, result in I discovered exactly what I was having a
    look for. You have ended my 4 day lengthy hunt! God Bless you man. Have
    a great day. Bye

    For whatever cause my private web browser doesn?capital t display this page correctly? Anyhow, it was a really interesting post, continue the excellent function and I will likely be back once more for extra

Leave a Reply

Your email address will not be published.